Cursiefen C - Search Results

1

[Immune reactions after DMEK, DSAEK and DALK].

Steven P, Hos D, Heindl LM, Bock F, Cursiefen C. Steven P, et al. Among authors: cursiefen c. Klin Monbl Augenheilkd. 2013 May;230(5):494-9. doi: 10.1055/s-0032-1328257. Epub 2013 Feb 27. Klin Monbl Augenheilkd. 2013. PMID: 23446757 Review. German.

2

[Standardized semiquantitative analysis of corneal neovascularization using projected corneal photographs--pilot study after perforating corneal keratoplasty before immune reaction].

Cursiefen C, Wenkel H, Martus P, Langenbucher A, Seitz B, Küchle M. Cursiefen C, et al. Klin Monbl Augenheilkd. 2001 Jul;218(7):484-91. doi: 10.1055/s-2001-16291. Klin Monbl Augenheilkd. 2001. PMID: 11512248 Clinical Trial. German.

3

[Immunological graft reactions after penetrating keratoplasty - A prospective randomized trial comparing corneal excimer laser and motor trephination].

Seitz B, Langenbucher A, Diamantis A, Cursiefen C, Küchle M, Naumann GO. Seitz B, et al. Among authors: cursiefen c. Klin Monbl Augenheilkd. 2001 Nov;218(11):710-9. doi: 10.1055/s-2001-18662. Klin Monbl Augenheilkd. 2001. PMID: 11731898 Clinical Trial. German.

4

[Clinical aspects and treatment of immune reactions following penetrating normal-risk keratoplasty].

Nguyen NX, Seitz B, Langenbucher A, Wenkel H, Cursiefen C. Nguyen NX, et al. Among authors: cursiefen c. Klin Monbl Augenheilkd. 2004 Jun;221(6):467-72. doi: 10.1055/s-2004-813282. Klin Monbl Augenheilkd. 2004. PMID: 15236106 Clinical Trial. German.

5

[Inhibition of angiogenesis in the anterior chamber of the eye].

Bock F, König Y, Dietrich T, Zimmermann P, Baier M, Cursiefen C. Bock F, et al. Among authors: cursiefen c. Ophthalmologe. 2007 Apr;104(4):336-44. doi: 10.1007/s00347-007-1512-2. Ophthalmologe. 2007. PMID: 17372736 Review. German.

6

Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation.

Bock F, Onderka J, Dietrich T, Bachmann B, Pytowski B, Cursiefen C. Bock F, et al. Among authors: cursiefen c. Graefes Arch Clin Exp Ophthalmol. 2008 Jan;246(1):115-9. doi: 10.1007/s00417-007-0683-5. Epub 2007 Oct 2. Graefes Arch Clin Exp Ophthalmol. 2008. PMID: 17909835

7

Bevacizumab (Avastin) eye drops inhibit corneal neovascularization.

Bock F, König Y, Kruse F, Baier M, Cursiefen C. Bock F, et al. Among authors: cursiefen c. Graefes Arch Clin Exp Ophthalmol. 2008 Feb;246(2):281-4. doi: 10.1007/s00417-007-0684-4. Epub 2007 Oct 13. Graefes Arch Clin Exp Ophthalmol. 2008. PMID: 17934753

8

Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation.

Bachmann BO, Bock F, Wiegand SJ, Maruyama K, Dana MR, Kruse FE, Luetjen-Drecoll E, Cursiefen C. Bachmann BO, et al. Among authors: cursiefen c. Arch Ophthalmol. 2008 Jan;126(1):71-7. doi: 10.1001/archopht.126.1.71. Arch Ophthalmol. 2008. PMID: 18195221

9

Histologic analysis of descemet stripping in posterior lamellar keratoplasty.

Heindl LM, Hofmann-Rummelt C, Schlötzer-Schrehardt U, Kruse FE, Cursiefen C. Heindl LM, et al. Among authors: cursiefen c. Arch Ophthalmol. 2008 Apr;126(4):461-4. doi: 10.1001/archophthalmol.2007.75. Arch Ophthalmol. 2008. PMID: 18413512

10

Inflammatory corneal (lymph)angiogenesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation.

Hos D, Bock F, Dietrich T, Onderka J, Kruse FE, Thierauch KH, Cursiefen C. Hos D, et al. Among authors: cursiefen c. Invest Ophthalmol Vis Sci. 2008 May;49(5):1836-42. doi: 10.1167/iovs.07-1314. Invest Ophthalmol Vis Sci. 2008. PMID: 18436817

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

574 results

Search Page